BioNTech is more than just a company. It’s a symbol of Europe’s scientific courage.
The founders of BioNTech, Uğur Şahin and Özlem Türeci, have been awarded the Deutscher Nationalpreis 2025, one of Germany’s most prestigious honors. As Chancellor Olaf Scholz noted, this award recognizes not only their outstanding scientific achievements but also their exceptional personal courage.
Their story has long transcended the boundaries of biotechnology. It’s the story of how a team of scientists confronted a global pandemic, created the world’s first mRNA-based vaccine, and fundamentally changed the model of how science, business, and government interact.
Today, BioNTech is more than a pharma company. It’s a platform for next-generation therapies: mRNA-based oncology, vaccines against malaria and tuberculosis, and even fully personalized immunoprograms.
📌 In an era when trust in science is increasingly questioned, BioNTech’s story is a reminder: scientific entrepreneurship isn’t about risk for profit. It’s about risk for humanity.
Source: Handelsblatt
